118th Congress · HOUSE BILLBILL

H.R. 4134Updated Drug Labeling for Patient Safety Act

To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to establish a process to allow the holders of abbreviated new drug applications to make labeling changes to include new or updated safety-related information, and for other purposes.

Health
Introduced Jun 14, 2023
Last action Jun 16, 2023
Pipeline · Bill → Law
Step 1
Introduced
Jun 14, 2023
Step 2
Referred
Jun 16, 2023
E&C
Step 3
Committee
Step 4
House floor
Step 5
Senate
Step 6
Resolve Changes
Step 7
Signed
SummaryCRS Summary

This bill allows generic drug manufacturers to revise labels with updated safety information that differs from the referenced brand-name drug.

Provisions · 2 sectionsIntroduced in House
Timeline · 3 actions
Jun 16, 2023
Referred to the Subcommittee on Health.
Jun 14, 2023
Introduced in House
Jun 14, 2023
Referred to the House Committee on Energy and Commerce.